[ Price : $8.95]
The U.S. Court of Appeals for the Fifth Circuit upholds FDAs decision to remove tirzepatide from the agencys drug shortage list, a...[ Price : $8.95]
Reed Smith attorney James Beck says courts so far have rejected all arguments citing the Supreme Courts Loper Bright decision as a...[ Price : $8.95]
Celcuity files a supplemental NDA for Revtorpyk (gedatolisib) for treating certain patients with hormone receptor positive, human ...[ Price : $8.95]
FDA approves Revolution Medicines Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer.[ Price : $8.95]
CNBC reports that HHS plans to appoint two new FDA deputy commissioners in hopes of exerting more influence over the agency.[ Price : $8.95]
FDA says the Boston Scientific recall of its ENROUTE Transcarotid Neuroprotection System is Class 1.[ Price : $8.95]
Participants in a 4/23 FDA meeting on increasing access to nonprescription drugs see a need to improve the electronic health recor...[ Price : $8.95]
An oncology physician association says its members are reporting a shortage of the chemotherapy agent ifosfamide for which no dire...